Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Notes Payables: 2019-2025

Historic Notes Payables for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $592,000.

  • Burning Rock Biotech's Notes Payables was N/A to $592,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $592,000, marking a year-over-year change of. This contributed to the annual value of $82,389 for FY2024, which is N/A change from last year.
  • Per Burning Rock Biotech's latest filing, its Notes Payables stood at $592,000 for Q2 2025, which was up 618.31% from $82,416 recorded in Q4 2024.
  • Burning Rock Biotech's 5-year Notes Payables high stood at $592,000 for Q2 2025, and its period low was $82,416 during Q4 2024.
  • Its 2-year average for Notes Payables is $337,208, with a median of $337,208 in 2024.
  • Data for Burning Rock Biotech's Notes Payables shows a maximum YoY crashed of 66.55% (in 2021) over the last 5 years.
  • Quarterly analysis of 4 years shows Burning Rock Biotech's Notes Payables stood at $372,000 in 2021, then followed by $157,000 in 2022, then followed by $82,416 in 2024, then followed by $592,000 in 2025.
  • Its last three reported values are $592,000 in Q2 2025, $82,416 for Q4 2024, and $157,000 during Q2 2022.